Slides: Understanding CKD & SGLT2 inhibition: What are the key mechanisms for benefit?
Presentation prof Groop
Slides (presentation) - June 27, 2018 - ERA-EDTA 2018, Copenhagen - Per-Henrik Groop, MD Helsinki University and Helsinki University Hospital, FinlandThis lecture by prof. Per-Henrik Groop part of a CME accredited symposium: Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibition held at ERA-EDTA 2018 in Copenhagen. Slides are available as an educational service to PACE members and meeting participants
View presentation slides
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: